One-year outcomes of ziv-aflibercept for macular edema in central retinal vein occlusion

Purpose: To report the 12-month efficacy and safety outcomes of intravitreal ziv-aflibercept in macular edema secondary to central retinal vein occlusion (CRVO). Methods: Interventional case series documenting 12-month outcomes of intravitreal ziv-aflibercept (1.25 mg in 0.05 mL) in 6 patients with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mohab Eldeeb, Errol W. Chan, Chintan J. Dedhia, Ahmad Mansour, Jay Chhablani
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2017-12-01
Colección:American Journal of Ophthalmology Case Reports
Materias:
Ziv-aflibercept
Anti-vascular endothelial factor (anti-VEGF)
Macular edema
Central retinal vein occlusion (CRVO)
Optical coherence tomography (OCT)
Acceso en línea:http://www.sciencedirect.com/science/article/pii/S2451993617300336
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares